Soleno Therapeutics (NASDAQ:SLNO) Given New $102.00 Price Target at Robert W. Baird
Soleno Therapeutics (NASDAQ:SLNO – Free Report) had its target price boosted by Robert W. Baird from $72.00 to $102.00 in a research note published on Thursday,Benzinga reports. Robert W. Baird currently has an outperform rating on the stock. Several other equities analysts also recently weighed in on SLNO. Lifesci Capital upgraded Soleno Therapeutics to a […]
More Stories
Retail Sales Jumped 1.4 Percent in March Amid Rush to Beat Tariffs
By Katabella Roberts Retail sales in the United States were stronger than expected in March, driven, in part, by a...
Innovative Therapy Reverses Lung and Nerve Damage from COVID-19
By Jingduan Yang M.D. Many of us who have been infected with the COVID-19 virus face long-term health challenges, including lung...
Vehicle Affordability Improved to Best Level in 45 Months: Report
By Naveen Athrappully March was the best time for buying a car in more than three years in terms of...
Honda Shifting Production of Civic Hybrid to US From Japan
By Austin Alonzo Japanese automaker Honda Motor Co. will move its production of the five-door Civic hybrid model to Indiana...
Trump Signs Order Barring Illegal Immigrants From Receiving Social Security
By T.J. Muscaro President Donald Trump signed a memorandum on April 15 directing several federal agencies to take measures to...
Invesco Ltd. Grows Stake in Patterson-UTI Energy, Inc. (NASDAQ:PTEN)
Invesco Ltd. increased its position in Patterson-UTI Energy, Inc. (NASDAQ:PTEN – Free Report) by 27.8% during the fourth quarter, HoldingsChannel.com...